Showing results (191-200 of 232) with videos related to

Sort By:
Pageof 24
Oncology Letters|December 3, 2019
High efficacy and safety of VTD as an induction protocol in patients with newly diagnosed multiple myeloma eligible for high dose therapy and autologous stem cell transplantation: A report of the Polish Myeloma Study GroupIwona Hus, Joanna Mańko, Dariusz Jawniak, et al.
Leukemia & Lymphoma|January 5, 2016
Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patientsArtur Jurczyszyn, Magdalena Olszewska-Szopa, Vania Hungria, et al.
Leukemia & Lymphoma|July 7, 2020
Primary refractory multiple myeloma: a real-world experience with 85 casesArtur Jurczyszyn, Anna Waszczuk-Gajda, Jorge J Castillo, et al.
Antibiotics (Basel, Switzerland)|April 3, 2021
Mortality Following Clostridioides difficile Infection in Europe: A Retrospective Multicenter Case-Control StudyJacek Czepiel, Marcela Krutova, Assaf Mizrahi, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 30, 2021
POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter AnalysisArtur Jurczyszyn, Jorge J Castillo, Magdalena Olszewska-Szopa, et al.
Oncotarget|July 21, 2016
A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysisRafael Ríos-Tamayo, Carmen Belén Lupiañez, Daniele Campa, et al.
Cancers|July 14, 2023
The Real-World Evidence on the Fragility and Its Impact on the Choice of Treatment Regimen in Newly Diagnosed Patients with Multiple Myeloma over 75 Years of AgeAgata Tyczyńska, Marcela Krzysława Krzempek, Alexander Jorge Cortez, et al.
Transplantation Proceedings|March 31, 2020
Negative Impact of Borderline Creatinine Concentration and Glomerular Filtration Rate at Baseline on the Outcome of Patients With Multiple Myeloma Treated With Autologous Stem Cell TransplantAnna Waszczuk-Gajda, Jolanta Małyszko, David H Vesole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statementMeletios A Dimopoulos, Jens Hillengass, Saad Usmani, et al.
Leukemia & Lymphoma|November 21, 2019
Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortiumElżbieta Iskierka-Jażdżewska, Federico Canzian, Anna Stępień, et al.
Pageof 24